CVS Health Corporation (CVS)
CVS Health (CVS) Reports Q4 Earnings: What Key Metrics Have to Say
The headline numbers for CVS Health (CVS) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
CVS Health posts strong Q4 revenue, raises full-year guidance
CVS Health Corp (NYSE:CVS) on Tuesday reported stronger-than-expected fourth-quarter revenue and adjusted earnings, driven by growth across its pharmacy, health services, and insurance businesses. The US pharmacy chain and health insurer said fourth-quarter revenue rose 8.2% to $105.7 billion, topping analysts' expectations of $103.6 billion.
CVS Health (CVS) Tops Q4 Earnings and Revenue Estimates
CVS Health (CVS) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $1.19 per share a year ago.
The CVS Earnings Bombshell That Has Investors Scrambling Right Now
CVS Health (NYSE: CVS) delivered a solid revenue beat in Q4 2025, though adjusted earnings declined year-over-year despite exceeding Wall Street expectations.
CVS Stock Falls After Earnings Beat. Why Medicare Worries Persist.
CVS Health earnings came in ahead of analyst forecasts but the company is concerned about Medicare rates.
CVS Health's turnaround is paying off amid widespread changes to health insurance and retail pharmacy businesses
The healthcare giant saw its revenue jump 8% in the fourth quarter
CVS Profit, Revenue Climb as Turmoil Continues in Health-Insurance Sector
CVS Health reported earnings that beat analysts' expectations and kept its 2026 profit guidance unchanged, results that may soothe investors spooked by continued turmoil in the health-insurance sector.
What Analyst Projections for Key Metrics Reveal About CVS Health (CVS) Q4 Earnings
Besides Wall Street's top-and-bottom-line estimates for CVS Health (CVS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.
CVS Health (CVS) Suffers a Larger Drop Than the General Market: Key Insights
The latest trading day saw CVS Health (CVS) settling at $75.24, representing a -2.07% change from its previous close.
Will Pharmacy and Consumer Wellness Segment Lead CVS' Q4 Earnings?
CVS Health may report higher Q4 revenues, led by prescription growth and expanded pharmacy operations.
CVS Health: Exploit The Sector Panic Ahead Of Earnings
CVS Health remains well-positioned despite a sector-wide selloff after disappointing Medicare rate increases and UnitedHealth's outlook. CVS's early restructuring, cost cuts, and reduced Medicare exposure have prepared it better than peers for current industry headwinds. At 10–11x forward earnings, CVS trades at a discount to peers, with potential for multiple expansion if execution continues.
CVS Health (CVS) Expected to Beat Earnings Estimates: Should You Buy?
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
